Novo Nordisk says Wegovy pill outperforms Lilly’s oral GLP-1 in cross-trial comparison
--------------------------------------------------------------------
Source: CNBC
Published: 2026-04-02 23:00 UTC+10:00
Section: General
Factuality Score: 100
Opinion Category: Neutral
Topics: Economy & Finance, Financial Markets, Law & Courts, Business & Economy, Crime & Justice
--------------------------------------------------------------------
Snippet:
The Wegovy pill showed more pronounced weight loss and less cumbersome side effects than Eli Lilly's rival pill that was approved this week, Novo Nordisk said Thursday.
--------------------------------------------------------------------